Clinical Trials in Illinois

Showing 11641-11660 of 19,692 trials

Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology

NCT03962790

This study is a multi-site, randomized, double-masked, 2×2 crossover design, 1-week dispensing study. Subjects will wear both Test and Control lenses in each eye in a random order for 1-week each as a daily disposable modality with a wash-out period of 1 week between the wearing periods.

Visual Acuity

Johnson & Johnson Vision Care, Inc.95 participantsStarted May 2019

Maitland, Florida, United States • Bloomington, Illinois, United States • New York, New York, United States +3 more locations

COMPLETEDPhase 335 miles

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

NCT00005970

This randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and trastuzumab to see how well they work compared to combination chemotherapy alone in treating women with breast cancer that is human epidermal growth factor receptor 2 (HER2)-positive and has spread to the lymph nodes or high-risk and has not spread to the lymph nodes. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as trastuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether combination chemotherapy is more effective with or without trastuzumab in treating breast cancer.

Breast AdenocarcinomaHER2 Positive Breast CarcinomaStage IA Breast Cancer AJCC v7+4 more

National Cancer Institute (NCI)3,436 participantsStarted May 2000

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +154 more locations

Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Manufacturing Technology

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Find Trials by Condition in Illinois

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Performance Improvement Program on Imaging II

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

TMT Fusion Plate vs. Two Crossed Screws

A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

Prospective Multicenter Trial to Compare Preformed vs Non Preformed Orbital Implants